Oral hypoglycaemic agents in the treatment of immunogenic insulin resistance in NIDDM.
D000328:Adult; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007330:Insulin Antibodies / Q000032:analysis; D007333:Insulin Resistance / Q000187:drug effects*; D008297:Male; D008875:Middle Aged
D007004:Hypoglycemic Agents; D007330:Insulin Antibodies